White House Says Trump Drug Deals Could Save $529B

The White House estimates that President Donald Trump’s drug pricing deals with pharmaceutical companies could save the U.S. economy $529 billion over the next decade, according to an analysis reported by the Associated Press.

The report said the policy aims to align U.S. prescription drug prices with those in other developed countries. Officials from the White House Council of Economic Advisers also projected $64.3 billion in savings for Medicaid over 10 years under the “most favored nation” framework.

BREAKING: President Trump's drugmaker deals may save the economy $529 billion over 10 years, according to a White House analysis obtained by the AP. https://t.co/lusLlVeVSw

— The Associated Press (@AP) May 5, 2026

However, details of the agreements with 17 drugmakers have not been fully disclosed, raising questions about transparency. Democratic lawmakers have challenged the administration’s claims and called for greater disclosure.

According to government data, Americans spent $467 billion on prescription drugs in 2024, underscoring the stakes. The administration argues the policy will reduce costs while preserving innovation, though critics warn potential trade-offs.

Also Read:

Deadly Virus Outbreak Strands Cruise Ship Off Africa

Nearly 150 people remain stranded aboard a cruise ship off West Africa after a suspected hantavirus outbreak killed at least three passengers, according to a report by CNN. The MV Hondius, operated by Oceanwide Expeditions, is anchored near Cape Verde after being denied entry to port over public health concerns.

tippinsightsTIPP Staff